Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration

Friday, October 26, 2018 1 min read

Key Takeaway: Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration

Full Press Release Details

Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration.